Arbutus Biopharma Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Arbutus Biopharma stock has a consensus rating of "Strong Buy" and an average price target of $5.05. The average 1-year stock price forecast is 10.26% higher than the current stock price, while the lowest is $4.80 (+4.80%) and the highest is $5.31 (+15.94%).

Price Target: $5.05 (+10.26%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.80	$5.05	$5.05	$5.31
Change	+4.80%	+10.26%	+10.26%	+15.94%

Analyst Ratings

The average analyst rating for Arbutus Biopharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	2

Financial Forecast

Revenue This Year

181.40M

from 14.08M

1,188.06%

from 14.08M

Revenue Next Year

2.70M

from 181.40M

-98.51%

from 181.40M

EPS This Year

-0.16

from -0.17

EPS Next Year

-0.05

from -0.16

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	10.99M	39.02M	18.14M	6.17M	14.08M	181.40M
Revenue Growth	58.92%	255.11%	-53.51%	-65.98%	128.21%	1,188.06%
Gross Profit	-54.51M	-45.39M	-55.56M	-47.87M	-11.16M	158.72M
Gross Margin	-496.12%	-116.33%	-306.26%	-775.66%	-79.23%	87.50%
Operating Income	-71.65M	-63.22M	-78.03M	-69.97M	-27.05M	153.17M
Net Income	-76.25M	-69.46M	-72.85M	-69.92M	-33.50M	156.27M
EPS	-	-	-	-	-0.17	-0.16
Free Cash Flow	-38.42M	-9.73M	-51.58M	-39.23M	-17.62M	10.03M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	181.4M
Avg	181.4M
Low	181.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	1,188.1%
Avg	1,188.1%
Low	1,188.1%

EPS Forecast

EPS	2026	2027	2028
High	-0.16
Avg	-0.16
Low	-0.16

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-